RNTX Rein Therapeutics, Inc. - Common Stock
$0.81
가격 · 8월 19, 2026
기준 재무 정보 8월 14, 2026
RNTX 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.81
시가총액
—
P/E (TTM)
-0.6
EPS (TTM)
$-1.96
매출 (TTM)
$0
배당 수익률
—
ROE
—
부채/자본
—
52주 범위
$1 – $2
RNTX 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$0
2016-12-31
→
2025-12-31
EPS
$-1.96
2021-12-31
→
2025-12-31
잉여현금흐름
—
2017-12-31
→
2021-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
RNTX
동종업계 중앙값
P/E (TTM)
-0.6
4.7
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
RNTX
동종업계 중앙값
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
RNTX
동종업계 중앙값
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
RNTX
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
RNTX
동종업계 중앙값
RNTX 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
9 명의 애널리스트
- 적극 매수 2 22.2%
- 매수 5 55.6%
- 보유 2 22.2%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
2 명의 애널리스트 · 2026-08-16
중앙값
$6.00
← 모든 목표가 하회
$0.81
저가
$4.00
고가
$8.00
중앙값 목표
$6.00
+645.2%
평균 목표
$6.00
+645.2%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.44%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.19 | $-0.50 | 0.31% |
| 2025년 12월 31일 | $-1.09 | $-0.22 | -0.87% |
| 2025년 9월 30일 | $-0.21 | $-0.24 | 0.03% |
| 2025년 6월 30일 | $-0.28 | $-0.22 | -0.06% |
| 2025년 3월 31일 | $-0.25 | $-0.25 | -0.00% |
| 2024년 12월 31일 | $-2.20 | $-0.14 | -2.1% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| RNTX | — | -0.6 | — | — | — | — |
| ANVS | $94M | -2.5 | — | — | -164.0% | — |
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| NMAD | — | — | — | — | — | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| CTOR | $170M | -6.0 | — | — | -61.5% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $11M | $14M | $4M | $18M | $17M | $11M | $18M | $18M | $14M | $10M | |
| SG&A Expense | $11M | $14M | $11M | $10M | $10M | $9M | $12M | $13M | $9M | $8M | |
| Operating Expenses | $51M | $65M | $16M | $28M | $27M | $20M | $30M | $32M | $23M | $18M | |
| Operating Income | $-51M | $-65M | $-16M | $-28M | $-27M | $-20M | $-30M | $-32M | $-23M | $-18M | |
| Other Non-op | $48.0K | $685.0K | $544.0K | $318.0K | $441.0K | $-661.0K | $587.0K | · | · | · | |
| Income Tax | $-712.0K | $-2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-50M | $-63M | $-16M | $-27M | $-26M | $-27M | $-29M | $-32M | $-23M | $-18M | |
| EPS (Basic) | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 | · | · | · | · | · | |
| EPS (Diluted) | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 | · | · | · | · | · | |
| Shares (Basic) | 25,444,795 | 17,938,899 | 4,598,715 | 4,539,318 | 4,440,338 | · | · | · | · | · | |
| Shares (Diluted) | 25,444,795 | 17,938,899 | 4,598,715 | 4,539,318 | 4,440,338 | · | · | · | · | · | |
| EBITDA | · | · | · | · | $-26M | $-20M | $-30M | · | $-23M | · |
대차대조표 25
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $13M | $17M | $5M | $4M | $7M | $5M | $11M | $12M | $21M | |
| Short-term Investments | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $792.0K | $882.0K | $606.0K | $2M | $2M | $1M | $1M | $1M | $333.0K | |
| Other Current Assets | $881.0K | $676.0K | $675.0K | $606.0K | · | · | · | · | · | · | |
| Current Assets | $4M | $14M | $18M | $22M | $48M | $16M | $20M | $22M | $52M | $21M | |
| PP&E (Net) | $0 | $1.0K | $19.0K | $70.0K | $128.0K | $15.0K | $295.0K | $7M | $154.0K | $107.0K | |
| PP&E (Gross) | · | · | $377.0K | $340.0K | $340.0K | $181.0K | $817.0K | $8M | $2M | $2M | |
| Accum. Depreciation | · | · | $358.0K | $270.0K | $212.0K | $166.0K | $522.0K | $1M | $2M | $2M | |
| Goodwill | $6M | $6M | $6M | · | · | · | · | · | · | · | |
| Intangibles | $14M | $42M | $79M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2.0K | $2.0K | $2M | $24.0K | $24.0K | · | · | $679.0K | $694.0K | $778.0K | |
| Total Assets | $24M | $62M | $106M | $22M | $48M | $16M | $26M | $30M | $53M | $22M | |
| Accounts Payable | $4M | $911.0K | $1M | $2M | $1M | $2M | $1M | $2M | $2M | $2M | |
| Short-term Debt | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $6M | $6M | $4M | $3M | $5M | $4M | $6M | $5M | $5M | $4M | |
| Capital Leases | · | · | · | · | $69.0K | · | $5M | · | · | · | |
| Deferred Tax | $1M | $2M | $3M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $0 | $277.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $8M | $8M | $3M | $5M | $4M | $10M | $11M | $5M | $4M | |
| Common Stock | $113.0K | $108.0K | $91.0K | $91.0K | $91.0K | $44.0K | $28.0K | $15.0K | $15.0K | $0 | |
| Retained Earnings | $-401M | $-351M | $-289M | $-273M | $-245M | $-219M | $-198M | $-168M | $-137M | $-114M | |
| AOCI | $-62.0K | $-18.0K | $-63.0K | $-48.0K | $-13.0K | $-2.0K | $7.0K | $-5.0K | $-33.0K | · | |
| Stockholders' Equity | $17M | $54M | $98M | $19M | $44M | $12M | $16M | $20M | $48M | $-112M | |
| Liabilities + Equity | $24M | $62M | $106M | $22M | $48M | $16M | $26M | $30M | $53M | $22M | |
| Shares Outstanding | 27,550,222 | 21,666,012 | 4,885,512 | 4,541,167 | 4,528,667 | 2,190,208 | 27,810,358 | 14,748,475 | 14,723,818 | 432,413 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $63.0K | $119.0K | $169.0K | $121.0K | $163.0K | $155.0K | $218.0K | $129.0K | $232.0K | |
| Stock-based Comp | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $688.0K | |
| Deferred Tax | $-712.0K | $-2M | $0 | · | · | · | · | · | · | · | |
| Restructuring | · | $0 | $928.0K | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | $29.0K | $-1M | $624.0K | · | $195.0K | · | |
| Operating Cash Flow | $-19M | $-22M | $-20M | $-25M | $-24M | $-20M | $-26M | $-28M | $-21M | $-15M | |
| CapEx | · | · | · | · | $157.0K | $5.0K | $151.0K | $4M | $142.0K | · | |
| Investing Cash Flow | · | $0 | $16M | $26M | $-36M | $6M | $-3M | $25M | $-39M | · | |
| Stock Issued | $2M | $11M | $0 | · | · | $17M | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $17M | · | · | · | · | |
| Financing Cash Flow | $10M | $18M | $16M | · | $56M | $16M | $24M | $3M | $51M | · | |
| Net Change in Cash | $-10M | $-4M | $12M | $2M | $-4M | $2M | $-5M | $-723.0K | $-9M | $17M | |
| Free Cash Flow | · | · | · | · | $-24M | $-20M | $-27M | · | $-21M | · |
수익성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | · | · | -80.7% | -98.8% | -103.4% | · | -60.5% | · | |
| ROE | · | · | · | · | -55.7% | -171.9% | -151.1% | · | 70.6% | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 10.7 | 4.1 | 3.3 | · | 10.6 | · | |
| Quick Ratio | · | · | · | · | 0.8 | 1.8 | 0.9 | · | 2.4 | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
가치 평가 (TTM) 9
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-50M | $-63M | $-16M | $-27M | $-26M | $-27M | $-29M | $-32M | $-23M | · | |
| Market Cap | · | · | · | · | $1.02B | $911M | $319M | · | $3.10B | · | |
| P/E | -0.6 | -0.7 | -0.9 | -0.4 | -1.9 | · | · | · | · | · | |
| P/B | · | · | · | · | 23.2 | 74.9 | 19.9 | · | 64.9 | · | |
| P / Tangible Book | · | 8.5 | 1.2 | 0.6 | 23.2 | 74.9 | · | · | · | · | |
| P / Cash Flow | · | · | · | · | -42.9 | -44.5 | -12.0 | · | -151.2 | · | |
| P / FCF | · | · | · | · | -42.7 | -44.5 | -12.0 | · | -150.1 | · | |
| Earnings Yield | -169.0% | -152.6% | -112.2% | -254.0% | -52.3% | · | · | · | · | · |
손익계산서 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $4M | $3M | $2M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $2M | $22.0K | $187.0K | $2M | $2M | $4M | |
| SG&A Expense | $2M | $2M | $2M | $4M | $3M | $3M | $2M | $2M | $5M | $4M | $5M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $33M | $5M | $7M | $6M | $43M | $6M | $9M | $7M | $7M | $2M | $2M | $5M | $5M | $6M | |
| Operating Income | $-6M | $-5M | $-33M | $-5M | $-7M | $-6M | $-43M | $-6M | $-9M | $-7M | $-7M | $-2M | $-2M | $-5M | $-5M | $-6M | |
| Other Non-op | $-299.0K | $-608.0K | $-20.0K | $-89.0K | $49.0K | $108.0K | $272.0K | $224.0K | $97.0K | $92.0K | $-49.0K | $156.0K | $205.0K | $232.0K | $336.0K | $4.0K | |
| Net Income | $-6M | $-6M | $-32M | $-6M | $-7M | $-6M | $-41M | $-6M | $-9M | $-7M | $-7M | $-2M | $-2M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.10 | $-0.19 | $-1.22 | $-0.21 | $-0.28 | $-0.25 | $-1.93 | $-0.27 | $-0.45 | $-0.86 | $-1.58 | $-0.40 | $-0.39 | $-1.05 | $-1.00 | $-1.40 | |
| EPS (Diluted) | $-0.10 | $-0.19 | $-1.22 | $-0.21 | $-0.28 | $-0.25 | $-1.93 | $-0.27 | $-0.45 | $-0.86 | $-1.58 | $-0.40 | $-0.39 | $-1.05 | $-1.00 | $-1.40 | |
| Shares (Basic) | 67,084,661 | 30,354,647 | -47,020,018 | 26,361,386 | 24,187,536 | 21,915,891 | -31,937,450 | 21,663,089 | 19,911,462 | 8,301,798 | -9,024,786 | 4,541,167 | 4,541,167 | 4,541,167 | -9,076,719 | 4,541,179 | |
| Shares (Diluted) | 67,084,661 | 30,354,647 | -47,020,018 | 26,361,386 | 24,187,536 | 21,915,891 | -31,937,450 | 21,663,089 | 19,911,462 | 8,301,798 | -9,024,786 | 4,541,167 | 4,541,167 | 4,541,167 | -9,076,719 | 4,541,179 | |
| EBITDA | $-6M | $-5M | · | $-5M | $-7M | $-6M | · | $-6M | $-9M | $-7M | · | $-2M | $-2M | $-5M | · | $-6M |
대차대조표 25
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $3M | $4M | $6M | $7M | $13M | $18M | $22M | $12M | $17M | $12M | $13M | $8M | $5M | $5M | |
| Short-term Investments | $32M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $806.0K | $1M | $1M | $1M | $880.0K | $903.0K | $792.0K | $1M | $1M | $697.0K | $882.0K | $699.0K | $261.0K | $359.0K | $606.0K | $2M | |
| Other Current Assets | $727.0K | $918.0K | $881.0K | $997.0K | $692.0K | $864.0K | $676.0K | $755.0K | $304.0K | $547.0K | $675.0K | · | · | · | $606.0K | · | |
| Current Assets | $41M | $5M | $4M | $5M | $7M | $8M | $14M | $19M | $23M | $13M | $18M | $13M | $14M | $17M | $22M | $27M | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $6.0K | $19.0K | $29.0K | $39.0K | $52.0K | $70.0K | $84.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $340.0K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $295.0K | $285.0K | $272.0K | $270.0K | $256.0K | |
| Goodwill | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | · | · | · | · | · | |
| Intangibles | $14M | $14M | $14M | $42M | $42M | $42M | $42M | $79M | $79M | $79M | $79M | · | · | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2.0K | $2.0K | $2M | $766.0K | $2.0K | $2.0K | $709.0K | $892.0K | $2M | · | · | · | $24.0K | $24.0K | |
| Total Assets | $66M | $26M | $24M | $54M | $57M | $58M | $62M | $104M | $109M | $99M | $106M | $13M | $14M | $17M | $22M | $27M | |
| Accounts Payable | $4M | $6M | $4M | $4M | $6M | $1M | $911.0K | $1M | $782.0K | $2M | $1M | $484.0K | $136.0K | $458.0K | $2M | $945.0K | |
| Short-term Debt | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $10M | $14M | $6M | $6M | $8M | $6M | $6M | $6M | $5M | $5M | $4M | $2M | $1M | $3M | $3M | $5M | |
| Deferred Tax | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $277.0K | · | $116.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $11M | $15M | $7M | $8M | $9M | $8M | $8M | $9M | $8M | $8M | $8M | $2M | $1M | $3M | $3M | $5M | |
| Total Debt | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $172.0K | $114.0K | $113.0K | $111.0K | $109.0K | $108.0K | $108.0K | $108.0K | $107.0K | $103.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $-413M | $-407M | $-401M | $-369M | $-364M | $-357M | $-351M | $-310M | $-305M | $-296M | $-289M | $-281M | $-279M | $-278M | $-273M | $-268M | |
| AOCI | $-69.0K | $-62.0K | $-62.0K | $-44.0K | $-44.0K | $-32.0K | $-18.0K | $-26.0K | $-22.0K | $-63.0K | $-63.0K | · | $-2.0K | $-10.0K | $-48.0K | $-98.0K | |
| Stockholders' Equity | $55M | $12M | $17M | $46M | $48M | $50M | $54M | · | · | · | $98M | $11M | $13M | $14M | $19M | $23M | |
| Liabilities + Equity | $66M | $26M | $24M | $54M | $57M | $58M | $62M | $104M | $109M | $99M | $106M | $13M | $14M | $17M | $22M | $27M | |
| Shares Outstanding | 85,767,032 | 28,039,032 | 27,550,222 | 25,140,092 | 23,046,121 | 22,005,317 | 21,666,012 | 21,665,941 | 21,625,085 | 16,842,512 | 4,885,512 | 4,541,167 | 4,541,167 | 4,541,167 | 4,541,167 | 90,823,597 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | $1.0K | $0 | $0 | $0 | $4.0K | $59.0K | $52.0K | $12.0K | $12.0K | $43.0K | $43.0K | $43.0K | |
| Stock-based Comp | $164.0K | $156.0K | $257.0K | $1M | $256.0K | $264.0K | $133.0K | $508.0K | $326.0K | $150.0K | $270.0K | $229.0K | $300.0K | $391.0K | $424.0K | $442.0K | |
| Restructuring | · | · | · | · | · | · | · | $0 | $0 | $0 | $-12.0K | $6.0K | $-88.0K | $1M | · | · | |
| Other Non-cash | · | · | · | · | · | $-938.0K | · | · | · | $2M | · | · | · | $-316.0K | · | · | |
| Operating Cash Flow | $-9M | $-3M | $-3M | $-4M | $-6M | $-6M | $-5M | $-4M | $-8M | $-5M | $-10M | $-2M | $-3M | $-5M | $-4M | $-7M | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $-96.0K | $542.0K | $8M | $7M | $5M | $4M | |
| Stock Issued | $53M | $354.0K | $1M | $0 | $-370.0K | $737.0K | $0 | $-292.0K | $11M | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $354.0K | · | · | · | $737.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $48M | $5M | $2M | $2M | $5M | $738.0K | $1.0K | $-446.0K | $18M | $0 | $16M | $0 | · | · | · | · | |
| Net Change in Cash | $4M | $1M | $-833.0K | $-2M | $-2M | $-5M | $-5M | $-4M | $10M | $-5M | $5M | $-1M | $5M | $3M | $355.0K | $-3M |
수익성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.3% | -13.9% | · | -7.1% | -8.2% | -7.0% | · | -10.0% | -14.5% | -12.2% | · | -9.1% | -7.5% | -16.7% | · | -15.5% | |
| ROE | -12.3% | -19.0% | · | -19.4% | -22.4% | -17.2% | · | · | · | · | · | -10.8% | -8.6% | -19.0% | · | -17.5% |
유동성 및 지급능력 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 0.4 | · | 0.9 | 0.9 | 1.4 | · | 3.3 | 4.7 | 2.8 | · | 7.9 | 11.7 | 5.9 | · | 6.0 | |
| Quick Ratio | 4.2 | 0.3 | · | 0.7 | 0.7 | 1.2 | · | 3.1 | 4.4 | 2.7 | · | 7.4 | 11.0 | 2.7 | · | 1.1 | |
| Debt / Equity | · | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-25M | $-24M | · | $-24M | $-27M | $-27M | · | $-24M | $-20M | $-16M | · | $-15M | $-21M | $-28M | · | $-29M | |
| Market Cap | $89M | $36M | · | $29M | $32M | $39M | · | $77M | $60M | $112M | · | $7M | $8M | $6M | · | $376M | |
| Enterprise Value | · | $37M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.3 | -1.4 | · | -1.1 | -1.1 | -1.0 | · | -1.8 | -1.3 | -2.5 | · | -0.5 | -0.4 | -0.2 | · | -0.8 | |
| P/B | 1.6 | 3.1 | · | 0.6 | 0.7 | 0.8 | · | · | · | · | · | 0.6 | 0.6 | 0.4 | · | 16.6 | |
| P / Tangible Book | 2.5 | · | · | · | · | 28.9 | · | · | · | · | · | 0.6 | 0.6 | 0.4 | · | 16.6 | |
| P / Cash Flow | · | -10.6 | · | · | · | -6.3 | · | · | · | -21.2 | · | · | · | -1.2 | · | · | |
| EV / EBITDA | · | -7.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -75.0% | -71.5% | · | -88.2% | -89.3% | -103.4% | · | -55.9% | -75.8% | -40.7% | · | -213.2% | -257.0% | -489.5% | · | -123.0% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $0 | $0 | $0 | $0 | $0 |
| 순이익 | $-50M | $-63M | $-16M | $-27M | $-26M |
| 희석 EPS | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | — | — | — | — | 10.7 |
| 당좌 비율 | — | — | — | — | 0.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | — | — | — | — | $-24M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 62개의 제출자 · $40.8M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 22 (+15 이전 분기 대비) | 6 (-3 이전 분기 대비) | 14 (+1 이전 분기 대비) | 5 (+1 이전 분기 대비) | +28.2M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Voss Capital, LP | $5,472,398 | 5,261,921 | 13.43% | 주식 |
| Cable Car Capital, LP | $5,402,800 | 5,195,000 | 13.25% | 주식 |
| ADAR1 Capital Management, LLC | $4,680,000 | 4,500,000 | 11.48% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,513,026 | 3,377,910 | 8.62% | 주식 |
| Ikarian Capital, LLC | $3,068,000 | 2,950,000 | 7.53% | 주식 |
| GREAT POINT PARTNERS LLC | $2,678,000 | 2,575,000 | 6.57% | 주식 |
| CITADEL ADVISORS LLC | $2,340,000 | 2,250,000 | 5.74% | 주식 |
| Velan Capital Investment Management LP | $1,768,000 | 1,700,000 | 4.34% | 주식 |
| Senvest Management, LLC | $1,280,131 | 1,230,895 | 3.14% | 주식 |
| BIOS Capital Management, LP | $1,272,960 | 1,224,000 | 3.12% | 주식 |
| VANGUARD GROUP INC | $1,158,284 | 998,521 | 2.84% | 주식 |
| Prosight Management, LP | $1,144,000 | 1,100,000 | 2.81% | 주식 |
| Bleichroeder LP | $1,040,000 | 1,000,000 | 2.55% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $925,028 | 889,450 | 2.27% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $674,814 | 648,787 | 1.66% | 주식 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | $532,074 | 511,610 | 1.31% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $397,816 | 382,515 | 0.98% | 주식 |
| STATE STREET CORP | $394,788 | 379,604 | 0.97% | 주식 |
| Empery Asset Management, LP | $385,667 | 370,834 | 0.95% | 주식 |
| Sigma Planning Corp | $367,824 | 353,677 | 0.90% | 주식 |
| Sequoia Financial Advisors, LLC | $260,000 | 250,000 | 0.64% | 주식 |
| GAGNON SECURITIES LLC | $238,233 | 229,070 | 0.58% | 주식 |
| Stonepine Capital Management, LLC | $226,760 | 218,038 | 0.56% | 주식 |
| Palogic Value Management, L.P. | $187,200 | 180,000 | 0.46% | 주식 |
| NORTHERN TRUST CORP | $166,109 | 159,720 | 0.41% | 주식 |
| Rock Creek Group LLC | $130,000 | 125,000 | 0.32% | 주식 |
| ABS Direct Equity Fund LLC | $130,000 | 125,000 | 0.32% | 주식 |
| Warberg Asset Management LLC | $100,980 | 99,000 | 0.25% | 주식 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $83,200 | 80,000 | 0.20% | 주식 |
| GOLDMAN SACHS GROUP INC | $82,976 | 79,785 | 0.20% | 주식 |
| UBS Group AG | $59,670 | 57,375 | 0.15% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $52,479 | 50,461 | 0.13% | 주식 |
| KCK LTD. | $52,055 | 22,341 | 0.13% | 주식 |
| XTX Topco Ltd | $47,590 | 45,760 | 0.12% | 주식 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $44,138 | 42,440 | 0.11% | 주식 |
| Americana Partners, LLC | $43,514 | 41,840 | 0.11% | 주식 |
| Prime Capital Investment Advisors, LLC | $37,555 | 36,111 | 0.09% | 주식 |
| Texas Capital Bank Wealth Management Services Inc | $37,487 | 36,045 | 0.09% | 주식 |
| SteelPeak Wealth, LLC | $34,320 | 33,000 | 0.08% | 주식 |
| Chicago Partners Investment Group LLC | $32,843 | 41,048 | 0.08% | 주식 |
| Qube Research & Technologies Ltd | $32,018 | 30,787 | 0.08% | 주식 |
| Meridian Wealth Advisors, LLC | $29,625 | 28,486 | 0.07% | 주식 |
| Savant Capital, LLC | $23,315 | 30,528 | 0.06% | 주식 |
| Gleason Group, Inc. | $23,285 | 22,389 | 0.06% | 주식 |
| Global Retirement Partners, LLC | $20,089 | 19,316 | 0.05% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $19,760 | 19,000 | 0.05% | 주식 |
| Cane Capital Partners, LLC | $18,720 | 18,000 | 0.05% | 주식 |
| Vanguard Global Advisers, LLC | $13,285 | 12,774 | 0.03% | 주식 |
| Cetera Investment Advisers | $12,212 | 11,742 | 0.03% | 주식 |
| MORGAN STANLEY | $6,978 | 6,710 | 0.02% | 주식 |
| BlackRock, Inc. | $5,969 | 5,739 | 0.01% | 주식 |
| Rockefeller Capital Management L.P. | $5,301 | 5,097 | 0.01% | 주식 |
| BARCLAYS PLC | $2,673 | 2,570 | 0.01% | 주식 |
| New Millennium Group LLC | $2,364 | 2,038 | 0.01% | 주식 |
| JFS WEALTH ADVISORS, LLC | $2,067 | 1,590 | 0.01% | 주식 |
| US BANCORP \DE\ | $1,300 | 1,250 | 0.00% | 주식 |
| NFSG Corp | $101 | 97 | 0.00% | 주식 |
| Blue Trust, Inc. | $21 | 20 | 0.00% | 주식 |
| Annandale Capital, LLC | $16 | 15,026 | 0.00% | 주식 |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | 주식 |
| Motiv8 Investments LLC | $0 | 25 | 0.00% | 주식 |
| ACADIAN ASSET MANAGEMENT LLC | $0 | 17 | 0.00% | 주식 |
회사 내부자 32 명의 내부자 · 10 임원 · 17 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| James Brian Windsor | President and Chief Executive Officer | 2026년 5월 8일 A | 27,046 | 1 | 0 | $25,000 |
| John P Longenecker PHD | President and CEO | 2018년 8월 10일 P | 10,000 | 0 | 0 | $0 |
| Joseph A., Yanchik III | President and Chief Executive Officer and Director | 2017년 7월 25일 A | — | 0 | 0 | $0 |
| Rick Wanstall | Chief Financial Officer and Treasurer | 2022년 3월 30일 A | — | 0 | 0 | $0 |
| Donald Dougherty | SVP & Chief Financial Officer | 2019년 4월 15일 A | 5,000 | 0 | 0 | $0 |
| Allen Annis | SVP, Research | 2022년 3월 30일 A | — | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 2022년 3월 30일 A | 75,000 | 0 | 0 | $0 |
| Satter Muneer A | In connection with its original investment, SMTP had a contractual right to designate one member of the Board of Directors of Ai | 2021년 1월 8일 P | 16,609,449 | 0 | 0 | $0 |
| Kathryn Gregory | SVP, Chief Business Officer | 2020년 1월 31일 A | 45,000 | 0 | 0 | $0 |
| Kira Nelson | Vice President, Finance and Operations | 2017년 7월 25일 A | — | 0 | 0 | $0 |
| Josef H Von Rickenbach | 이사 | 2026년 5월 27일 P | 62,514 | 4 | 0 | $49,701 |
| William Fairey | 이사 | 2025년 7월 23일 A | — | 0 | 0 | $0 |
| Reinhard J. Ambros | 이사 | 2025년 7월 23일 A | 5,800 | 0 | 0 | $0 |
| Manuel Aivado | 이사 | 2025년 7월 23일 A | 1,000 | 0 | 0 | $0 |
| Alan A Musso | 이사 | 2025년 7월 23일 A | — | 0 | 0 | $0 |
| Jodie Pope Morrison | 이사 | 2022년 6월 15일 A | — | 0 | 0 | $0 |
| Jeffrey Allen Bailey | 이사 | 2022년 6월 15일 A | 74,894 | 0 | 0 | $0 |
| Nolan Howard Sigal | 이사 | 2022년 6월 15일 A | — | 0 | 0 | $0 |
| William Mckee | 이사 | 2022년 6월 15일 A | — | 0 | 0 | $0 |
| John H Mcarthur | 이사 | 2019년 6월 19일 A | — | 0 | 0 | $0 |
| Caleb Maxfield Winder | 이사 | 2018년 6월 21일 A | — | 0 | 0 | $0 |
| Armen Shanafelt | 이사 | 2018년 6월 21일 A | 1,094,987 | 0 | 0 | $0 |
| Brian M. Gallagher Jr. | 이사 | 2017년 7월 25일 A | 1,431,519 | 0 | 0 | $0 |
| Scott Kapnick | 이사 | 2017년 7월 5일 P | 66,666 | 0 | 0 | $0 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 10% 소유주 | 2024년 6월 17일 S | 1,746,549 | 0 | 0 | $0 |
| Apple Tree Partners II - Annex, L.P. | 10% 소유주 | 2018년 7월 6일 J | 0 | 0 | 0 | $0 |
| APPLE TREE PARTNERS II LP | 10% 소유주 | 2018년 7월 6일 J | 0 | 0 | 0 | $0 |
| AJU IB Investment Co., Ltd. | 10% 소유주 | 2017년 7월 5일 C | 517,558 | 0 | 0 | $0 |
| Sigma Emerging Markets Ltd. | 10% 소유주 | 2017년 7월 5일 C | 423,086 | 0 | 0 | $0 |
| KCK LTD. | 10% 소유주 | 2017년 7월 5일 C | 646,817 | 0 | 0 | $0 |
| Jon B. Platt | 10% 소유주 | 2017년 7월 5일 C | 90,318 | 0 | 0 | $0 |
| CVF, LLC | 10% 소유주 | 2017년 7월 5일 C | 716,180 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Muneer A. Satter ×3 제출 서류 | 2024년 4월 16일 | — | 최초 제출 | — | SEC |
| Muneer A. Satter (2) ×4 제출 서류 | 2021년 1월 8일 | — | 최초 제출 | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 제출 서류 | 2020년 4월 16일 | — | 최초 제출 | — | SEC |
| Lilly Ventures Fund I, LLC, LV Management Group, LLC, S. Edward Torres, Steven E. Hall, Ph.D., Armen B. Shanafelt, Ph.D. ×2 제출 서류 | 2019년 8월 13일 | — | 최초 제출 | — | SEC |
| Excel Medical Fund, L.P., Excel Medical Ventures, LLC, Juan Enriquez, Frederick R. Blume, Steven R. Gullans | 2017년 7월 13일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 4 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.